From 9-10 October 2014 around 200 scientists met at the Leipzig Fraunhofer Institute for Cell Therapy and Immunology for the ninth Fraunhofer Life Science Symposium. Held every two years, this year the event focused on the theme "Medicinal Cell Products and Stem Cells for Medicinal Applications".
In recent years biomedical research has revealed numerous promising new approaches for the prevention and treatment of serious illnesses. The issue of stem cells plays a key role in this. With the symposium the Fraunhofer IZI offers international scientists a platform on which they can discuss the latest developments in this field.
The scientific program encompasses three major subject areas: production, manufacture and application. In the first section a paper presented by Sarah Ferber (Centre for Stem Cells, Regenerative Medicine and Tissue Engineering, Sheba Medical Center, Tel Hashomer, Israel) was one major point of interest:
"Reprogramming the endocrine pancreas; autologous cell replacement therapy for diabetic patients". She spoke about the possibilities for transforming liver cells into insulin-producing cells.
In the future this method could possibly be used to help patients with type 1 diabetes, where the misdirected immune system destroys the body's own insulin-producing beta cells of the pancreas.
A further highlight was the paper presented by Nicole zur Nieden (University of California Riverside, Riverside CA, United States): "Stem cell-assisted drug discovery and risk assessment".
This illustrated various ways in which stem cell cultures can be used in the development of medicines and assessment of risks.
The aim here is to develop new methods and procedures that enable prognoses of effectiveness and toxicity in humans at an early stage of medicine development, with a higher degree of certainty than was previously achieved.
The Fraunhofer Life Science Symposium brings together up to 200 participants from academic and clinical institutions to discuss the various focal points concerning new technologies, trends and developments.
It is organized by the Fraunhofer Institute for Cell Therapy and Immunology IZI.
For further information see www.fs-leipzig.com.
Presse Institute | Fraunhofer-Gesellschaft
“Lasers in Composites Symposium” in Aachen – from Science to Application
19.09.2017 | Fraunhofer-Institut für Lasertechnik ILT
I-ESA 2018 – Call for Papers
12.09.2017 | Fraunhofer-Institut für Produktionsanlagen und Konstruktionstechnik IPK
Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...
Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!
When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...
For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.
Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...
MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.
MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...
Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
20.09.2017 | Life Sciences
20.09.2017 | Power and Electrical Engineering
20.09.2017 | Physics and Astronomy